Catalyst Wire Dossier Catalyst Wire Dossier

CPNA peanut OIT

peanut oral immunotherapy · Aimmune Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPNA peanut OIT, covering 2021-11-09 to 2021-11-09. Get the full timeline:

Most recent: Clinical Trial Update: Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study [Phase 2]

See pricing